Get started
Author

Isabelle Plantier

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
2010 · Bertrand Coiffier, Catherine Thieblemont, et al. · Blood · 1,576
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study
2017 · Caroline Charlier, Élodie Perrodeau, et al. · The Lancet Infectious Diseases · 601
PDF
Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system [see comments]
1996 · B Dupriez, P Morel, et al. · Blood · 523
Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine
2010 · Raphael Itzykson, Sylvain Thépot, et al. · Blood · 385
Primary Anaplastic Large-Cell Lymphoma in Adults: Clinical Presentation, Immunophenotype, and Outcome
1997 · Hervé Tilly, Philippe Gaulard, et al. · Blood · 171
Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry
2012 · Sarah Beaussant Cohen, Odile Fenneteau, et al. · Orphanet Journal of Rare Diseases · 144
PDF
Azacitidine in untreated acute myeloid leukemia: A report on 149 patients
2013 · Sylvain Thépot, Raphael Itzykson, et al. · American Journal of Hematology · 102
PDF
Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk
2019 · Jill Corre, Lydia Montes, et al. · Haematologica · 89
PDF
Azacitidine for the treatment of relapsed and refractory AML in older patients
2014 · Raphael Itzykson, Sylvain Thépot, et al. · Leukemia Research · 70
Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia
2003 · Joris Andrieux, Jean‐Loup Demory, et al. · Genes Chromosomes and Cancer · 58
Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22 + Philadelphia Chromosome–Negative B-Cell Precursor Acute Lymphoblastic Leukemia
2024 · Patrice Chevallier, Thibaut Leguay, et al. · Journal of Clinical Oncology · 49
Clinical Significance of ABCB1 in Acute Myeloid Leukemia: A Comprehensive Study
2019 · Thomas Boyer, Fanny Gonzales, et al. · Cancers · 40
PDF
Nilotinib with or without cytarabine for Philadelphia-positive acute lymphoblastic leukemia
2024 · Yves Chalandon, Philippe Rousselot, et al. · Blood · 34
Long-term outcome of imatinib 400 mg compared to imatinib 600 mg or imatinib 400 mg daily in combination with cytarabine or pegylated interferon alpha 2a for chronic myeloid leukaemia: results from the French SPIRIT phase III randomised trial
2021 · Francois Guilhot, Françoise Rigal-Huguet, et al. · Leukemia · 30
Fractionated Doses of Gemtuzumab Ozogamicin (GO) Combined to Standard Chemotherapy (CT) Improve Event-Free and Overall Survival in Newly-Diagnosed De Novo AML Patients Aged 50–70 Years Old: A Prospective Randomized Phase 3 Trial From the Acute Leukemia French Association (ALFA)
2011 · Sylvie Castaigne, Cécile Pautas, et al. · Blood · 29
Frequency of structural abnormalities of the long arm of chromosome 12 in myelofibrosis with myeloid metaplasia
2002 · Joris Andrieux, Jean Loup Demory, et al. · Cancer Genetics and Cytogenetics · 29
Inv(16) may be one of the only ‘favorable’ factors in acute myeloid leukemia: A report on 19 cases with prolonged follow-up
1994 · I. Plantier, J.L. Lai, et al. · Leukemia Research · 28
CYTOGENETIC AND MOLECULAR REMISSION IN A CASE OF ACUTE MYELOID LEUKAEMIA (AML) WITH INVERSION OF CHROMOSOME 16 (Inv(16)) AND PHILADELPHIA CHROMOSOME (Ph)
1992 · Claude Preudhomme, Jean Luc Lai, et al. · British Journal of Haematology · 27
Chronic myeloproliferative disorder with t(8;22)(p11;q11) can mime clonal cytogenetic evolution of authentic chronic myelogeneous leukemia
2008 · Steven Richebourg, Olivier Theisen, et al. · Genes Chromosomes and Cancer · 24
PDF
Fluorescence in situ hybridization characterization of ider(20q) in myelodysplastic syndrome
2008 · N. Douet‐Guilbert, J. L. Laï, et al. · British Journal of Haematology · 23
High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencing
2025 · Anaïs Schavgoulidze, Aurore Perrot, et al. · Blood · 21
Azacytidine (AZA) as First Line Therapy in AML: Results of the French ATU Program.
2009 · Sylvain Thépot, Raphael Itzykson, et al. · Blood · 21
Molecular prognostic factors in acute myeloid leukemia receiving first-line therapy with azacitidine
2015 · J Desoutter, J Gay, et al. · Leukemia · 19
Randomized Comparison of Standard Induction with Daunorubicin (DNR) for 3 Days vs Idarubicin (IDA) for 3 or 4 Days in AML pts Aged 50 to 70 and of Maintenance with Interleukin 2. Final Analysis of the ALFA 9801 Study.
2007 · Cecile Pautas, Xavier Thomas, et al. · Blood · 19
Acute myeloblastic leukemia (AML) with inv (16)(p13;q22) and the rare I type CBFβ-MYH11 transcript: report of two new cases
2002 · N Grardel, C Roumier, et al. · Leukemia · 16
Works count: 67
Citation count: 4,339
H-index: 21
I10-index: 31
Year
Topic
Type